Health and Fitness Health and Fitness
Thu, May 31, 2012
[ Thu, May 31st 2012 ] - Market Wire
CIT to Host Investor Day
[ Thu, May 31st 2012 ] - Market Wire
ITG Expands Patent Portfolio

Orexigen Therapeutics to Present at the Jefferies 2012 Global Healthcare Conference


Published on 2012-05-31 04:46:02 - Market Wire
  Print publication without navigation


Orexigen Therapeutics to Present at the Jefferies 2012 Global Healthcare Conference -- SAN DIEGO, May 31, 2012 /PRNewswire/ --

Orexigen Therapeutics to Present at the Jefferies 2012 Global Healthcare Conference

[ ]

SAN DIEGO, May 31, 2012 /PRNewswire/ -- Orexigen® Therapeutics, Inc. (Nasdaq: [ OREX ]) today announced that management will present a company overview at the Jefferies 2012 Global Healthcare Conference in New York. The presentation is scheduled for Wednesday, June 6th at 9:30 a.m. EDT at the Grand Hyatt New York. To listen to the live webcast or a replay of the presentation, please visit the Investor Relations section of the Company's website at [ www.orexigen.com ]. A replay will be available for 14 days after the event.

About Orexigen® Therapeutics

Orexigen Therapeutics, Inc. is a biopharmaceutical company focused on the treatment of obesity. The Company's lead product candidate is Contrave®, which has completed Phase III clinical trials and for which a New Drug Application has been submitted and reviewed by the FDA. The Company has also reached agreement with the FDA on a Special Protocol Assessment for the Contrave cardiovascular outcomes trial which the company plans to initiate this quarter. The Company's other product candidate, Empatic™, has completed Phase II clinical trials. Further information about the Company can be found at [ www.orexigen.com ].

 

Orexigen Contact:

Media Contact: 

McDavid Stilwell

Denise Powell

VP, Corporate Communications and Business Development

WCG

(858) 875-8629

(510) 703-9491

SOURCE Orexigen Therapeutics, Inc.

[ Back to top ]

RELATED LINKS
[ http://www.orexcigen.com ]